Effect of cyclic AMP-elevating agents on airway ciliary beat frequency in central and lateral airways in rat precision-cut lung slices

European Journal of Pharmacology

Volumn 635, Issue 1-3, 2010, Pages 177-183

  Wohlsen, Andrea ^a   Hirrle, Andrea ^a   Tenor, Hermann ^a   Marx, Degenhard ^a   Beume, Rolf ^a  

^a Nycomed GmbH   (Germany)

Author keywords

Ciliary beat frequency; COPD; PDE4; Roflumilast

Indexed keywords

CYCLIC AMP; FORSKOLIN; ROFLUMILAST; ROLIPRAM; TERBUTALINE;

AIRWAY; ANIMAL TISSUE; ARTICLE; CILIARY MOTILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; LUNG SLICE; MUCOCILIARY CLEARANCE; NONHUMAN; PRIORITY JOURNAL; RAT;

AMINOPYRIDINES; ANIMALS; BENZAMIDES; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; CYCLOPROPANES; DISSECTION; ENZYME INHIBITORS; FEMALE; FORSKOLIN; LUNG; MUCOCILIARY CLEARANCE; PROSTAGLANDINS; RATS; RATS, WISTAR; ROLIPRAM; TERBUTALINE; TIME FACTORS;

EID: 77952304047     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.03.005     Document Type: Article

References (41)

1. Barnette M.S., Christensen S.B., Essayan D.M., Grous M., Prabhakar U., Rush J.A., Kagey-Sobotka A., Torphy T.J. SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions. J. Pharmacol. Exp. Ther. 1998, 284:420-426.
2. Bousquet J., Aubier M., Sastre J., Izquierdo J.L., Adler L.M., Hofbauer P., Rost K.D., Harnest U., Kroemer B., Albrecht A., Bredenbroker D. Comparison of roflumilast, an oral anti-inflammatory, with beclomethasone dipropionate in the treatment of persistent asthma. Allergy 2006, 61:72-78.
3. Braiman A. Cilia and Mucus, From Development to Respiratory Defense 2001, 67-79. M. Salathe (Ed.).
4. Braiman A., Zagoory O., Priel Z. PKA induces Ca2+ release and enhances ciliary beat frequency in a Ca2+-dependent and -independent manner. Am. J. Physiol. 1998, 275:C790-C797.
5. Bundschuh D.S., Eltze M., Barsig J., Wollin L., Hatzelmann A., Beume R. In vivo efficacy in airway disease models of roflumilast, a novel orally active PDE4 inhibitor. J. Pharmacol. Exp. Ther. 2001, 297:280-290.
6. Calverley P.M., Rabe K.F., Goehring U.-M., Kristiansen S., Fabbri L.M., Martinez F.J. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 2009, 374:685-694.
7. Delmotte P., Sanderson M.J. Ciliary beat frequency is maintained at a maximal rate in the small airways of mouse lung slices. Am. J. Respir. Cell Mol. Biol. 2006, 35:110-117.
8. Devalia J.L., Sapsford R.J., Rusznak C., Toumbis M.J., Davies R.J. The effects of salmeterol and salbutamol on ciliary beat frequency of cultured human bronchial epithelial cells, in vitro. Pulm. Pharmacol. 1992, 5:257-263.
9. Dodge K.L., Khouangsathiene S., Kapiloff M.S., Mouton R., Hill E.V., Houslay M.D., Langeberg L.K., Scott J.D. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J. 2001, 20:1921-1930.
10. Fabbri L.M., Calverley P.M., Izquierdo-Alonso J.L., Bundschuh D.S., Brose M., Martinez F.J., Rabe K.F. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet 2009, 374:695-703.
11. Fazio F., Lafortuna C. Effect of inhaled salbutamol on mucociliary clearance in patients with chronic bronchitis. Chest 1981, 80:827-830.
12. Foster W.M., Langenback E.G., Bergofsky E.H. Respiratory drugs influence lung mucociliary clearance in central and peripheral ciliated airways. Chest 1981, 80:877-880.
13. Giembycz M.A. Phosphodiesterase-4: selective and dual-specificity inhibitors for the therapy of chronic obstructive pulmonary disease. Proc. Am. Thorac. Soc. 2005, 2:326-333.
14. Hatzelmann A., Schudt C. Anti-inflammatory and immunomodulatory potential of the novel PDE4 inhibitor roflumilast in vitro. J. Pharmacol. Exp. Ther. 2001, 297:267-279.
15. Haxel B.R., Schafer D., Klimek L., Mann W.J. Prostaglandin E2 activates the ciliary beat frequency of cultured human nasal mucosa via the second messenger cyclic adenosine monophosphate. Eur. Arch. Otorhinolaryngol. 2001, 258:230-235.
16. Ingels K.J., Kortmann M.J., Nijziel M.R., Graamans K., Huizing E.H. Factors influencing ciliary beat measurements. Rhinology 1991, 29:17-26.
17. Joki S., Saano V. Ciliary beat frequency at six levels of the respiratory tract in cow, dog, guinea-pig, pig, rabbit and rat. Clin. Exp. Pharmacol. Physiol 1994, 21:427-434.
18. Knowles M.R., Boucher R.C. Mucus clearance as a primary innate defense mechanism for mammalian airways. J. Clin. Invest. 2002, 109:571-577.
19. Kultgen P.L., Byrd S.K., Ostrowski L.E., Milgram S.L. Characterization of an A-kinase anchoring protein in human ciliary axonemes. Mol. Biol. Cell 2002, 13:4156-4166.
20. Lafortuna C.L., Fazio F. Acute effect of inhaled salbutamol on mucociliary clearance in health and chronic bronchitis. Respiration 1984, 45:111-123.
21. Lansley A.B., Sanderson M.J. Regulation of airway ciliary activity by Ca2+: simultaneous measurement of beat frequency and intracellular Ca2+. Biophys. J. 1999, 77:629-638.
22. Lansley A.B., Sanderson M.J., Dirksen E.R. Control of the beat cycle of respiratory tract cilia by Ca2+ and cAMP. Am. J. Physiol. 1992, 263:L232-L242.
23. Lipworth B.J. Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease. Lancet 2005, 365:167-175.
24. Martin C., Uhlig S., Ullrich V. Videomicroscopy of methacholine-induced contraction of individual airways in precision-cut lung slices. Eur. Respir. J. 1996, 9:2479-2487.
25. Morse D.M., Smullen J.L., Davis C.W. Differential effects of UTP, ATP, and adenosine on ciliary activity of human nasal epithelial cells. Am. J. Physiol. Cell Physiol. 2001, 280:C1485-C1497.
26. O'Byrne P.M., Gauvreau G. Phosphodiesterase-4 inhibition in COPD. Lancet 2009, 374:665-667.
27. Phalen R.F., Oldham M.J. Tracheobronchial airway structure as revealed by casting techniques. Am. Rev. Respir. Dis. 1983, 128:S1-S4.
28. Rabe K.F., Bateman E.D., O'Donnell D., Witte S., Bredenbroker D., Bethke T.D. Roflumilast-an oral anti-inflammatory treatment for chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2005, 366:563-571.
29. Rennard S., Knobil K., Rabe K.F., Morris A., Schachter N., Locantore N., Canonica W.G., Zhu Y., Barnhart F. The efficacy and safety of cilomilast in COPD. Drugs 2008, 68:3-57. Suppl.
30. Ressmeyer A.R., Larsson A.K., Vollmer E., Dahlen S.E., Uhlig S., Martin C. Characterisation of guinea pig precision-cut lung slices: comparison with human tissues. Eur. Respir. J. 2006, 28:603-611.
31. Salathe M. Regulation of mammalian ciliary beating. Annu. Rev. Physiol. 2007, 69:401-422.
32. Salathe M., Bookman R.J. Mode of Ca2+ action on ciliary beat frequency in single ovine airway epithelial cells. J. Physiol. 1999, 520(Pt 3):851-865.
33. Santa C.R., Landa J., Hirsch J., Sackner M.A. Tracheal mucous velocity in normal man and patients with obstructive lung disease: effects of terbutaline. Am. Rev. Respir. Dis. 1974, 109:458-463.
34. Schmid A., Sutto Z., Nlend M.C., Horvath G., Schmid N., Buck J., Levin L.R., Conner G.E., Fregien N., Salathe M. Soluble adenylyl cyclase is localized to cilia and contributes to ciliary beat frequency regulation via production of cAMP. J. Gen. Physiol. 2007, 130:99-109.
35. Souma T. The distribution and surface ultrastructure of airway epithelial cells in the rat lung: a scanning electron microscopic study. Arch. Histol. Jpn. 1987, 50:419-436.
36. Torphy T.J. Phosphodiesterase isozymes: molecular targets for novel antiasthma agents. Am. J. Respir. Crit. Care Med. 1998, 157:351-370.
37. Wills P.J., Cole P.J. Mucolytic and mucokinetic therapy. Pulm. Pharmacol. 1996, 9:197-204.
38. Wohlsen A., Uhlig S., Martin C. Immediate allergic response in small airways. Am. J. Respir. Crit. Care Med. 2001, 163:1462-1469.
39. Wohlsen A., Martin C., Vollmer E., Branscheid D., Magnussen H., Becker W.M., Lepp U., Uhlig S. The early allergic response in small airways of human precision-cut lung slices. Eur. Respir. J. 2003, 21:1024-1032.
40. Wollin L., Bundschuh D.S., Wohlsen A., Marx D., Beume R. Inhibition of airway hyperresponsiveness and pulmonary inflammation by roflumilast and other PDE4 inhibitors. Pulm. Pharmacol. Ther. 2006, 19:343-352.
41. Yeh H.C., Schum G.M., Duggan M.J. Anatomic models of the tracheobronchial and pulmonary regions of the rat. Anat. Rec. 1979, 195:483-492.